Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis
This study has been completed.
Sponsor:
National Taiwan University Hospital
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00728598
First received: August 1, 2008
Last updated: August 5, 2008
Last verified: August 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 1998 |
| Primary Completion Date: | December 1998 (Final data collection date for primary outcome measure) |